BioNTech plunges 15% following all-time high

Vaccine firm dips in run-up to first quarter results

BioNTech bounced back on Wednesday, having plunged by 15.3% in the previous day's session. 

The company had started the week by surging to a record high of $213.15, a 1,260% increase from the level at which it began trading in its October 2019 IPO.

The biotech firm's growth has come about thanks to its successful partnership with Pfizer in developing one of the first and most popular MRNA vaccines for COVID-19.

Surprise dip

Tuesday's dip was all the more surprising as that same day BioNTech's CEO Ugur Sahin revealed to a Financial Times conference panel that the company is set to request regulatory approval for a longer-lasting version of its COVID-19 vaccine.

What is your sentiment on BNTX?

170.27
Bullish
or
Bearish
Vote to see community's results!

BioNTech is set to publish its quarterly results at the start of next week. The performance of its larger vaccine partner, Pfizer, has further raised expectations. Reporting strong first-quarter earnings on Tuesday, the pharma giant also increased its annual sales expectations for the COVID-19 vaccine by 70%. 

Although the cause for Tuesday's sudden plunge remains unclear, BioNTech regained upward momentum on Wednesday, trading up 8.3% by mid-morning at $191.74. 

FURTHER READING: Oil prices rise after largest fall in crude stocks since January

The material provided on this website is for information purposes only and should not be regarded as investment research or investment advice. Any opinion that may be provided on this page is a subjective point of view of the author and does not constitute a recommendation by Currency Com Bel LLC or its partners. We do not make any endorsements or warranty on the accuracy or completeness of the information that is provided on this page. By relying on the information on this page, you acknowledge that you are acting knowingly and independently and that you accept all the risks involved.
iPhone Image
Trade the world’s top tokenised stocks, indices, commodities and currencies with the help of crypto or fiat
iMac Image
Trade the world’s top tokenised stocks, indices, commodities and currencies with the help of crypto or fiat
iMac Image